RELEVANCE OF STUDYING THE CLINICAL AND DYNAMIC FEATURES OF SCHIZOPHRENIA COMPLICATED BY NEW DRUGS
Abstract
Schizophrenia is one of the socially significant, disabling diseases. About one percent of the world's population, including in Kazakhstan, suffers from schizophrenia. The start of the disease, most often happens at a young age - from 18 to 25 years old, a young age is also the beginning of manifestations of deviant processes in the form of use of various psychoactive substances. The use of psychoactive substances can be the starting mechanism for the formation of manifest endogenous psychosis, can be integrated into the endogenous process and alter the clinical picture of the disease, which complicates the diagnostic process for practicing physicians and complicates the solution of social and rehabilitation issues for patients suffering from comorbid mental disorders in the form of schizophrenia and mental and behavioral disorders caused by the use of psychoactive substances.
The purpose: define relevance in patients with schizophrenia complicated by addiction to new drugs.
About the Authors
M. S. Redko
NEI «Kazakh-Russian Medical University»
Kazakhstan
Kazakhstan
senior lecturer
S. Z. Yeshimbetova
NEI «Kazakh-Russian Medical University»
Kazakhstan
Kazakhstan
MD, Professor
References
1. Altynbekov K.S. Optimization of psychiatric care for patients with schizophrenia in a hospital (clinical and therapeutic, organizational and pharmacoeconomical aspects), dis. DMN, P. PTB. 2017.
2. Wadley G. How psychoactive drugs shape human culture: A multi-disciplinary perspective // Brain research bulletin. 2016. Vol. 126. P. 138 - 151.
3. Mrykhin V.V., Antsyborov A.V. Designer drugs: a brief history, an attempt at systematization on the example of «spices» and «salts» (review)/ Interactive science | 11 2017 P. 36-39.
4. Golovko A.I. «Toxicological characteristics of designer drugs / Barinov V. A. [et al.] // Toxicology. - Vol. 16. - January 20, 2015.
5. Mitin A.V. Research of Smoking aromatic mixtures // Forensic examination. - 2010. - No. 1. - P. 30-39.
6. Rokhlina M.L. Drug Addiction. Substance abuse: mental disorders and behavioral disorders associated with the use of psychoactive substances / M.L. Rokhlin. Moscow: Litterra, 2010. 256 p.
7. Mendelevich V.D. obstetrics and gynecology: textbook / V.D. Mendelevich, Y.P. Sivolap. - Rostov R // D: Phoenix, 2017. - P. 338-340.
8. Asadullin A.R., Antseburov A.B. New psychoactive substances: an evolutionary dead end of drugs or first degree? // Medical Bulletin of Bashkortostan. Volume 12, No. 4 (70), 2017 C. 98-103.
9. Corazza O., From «Special K» to «Special M»: the evolution of the recreational use of ketamine and methoxetamine // O. Corazza, S. Assi, F. Schifano // CNS Neurosci. Ther. – 2013. – Vol. 19. – P. 454-460.
10. Nazimova S.V. Features of psychopathology and clinic of paroxysmal schizophrenia formed under the influence of exogenous factors, psychiatry (medical Sciences), Dis. KMN, Moscow - 2013.
Review
For citations:
Redko M.S., Yeshimbetova S.Z. RELEVANCE OF STUDYING THE CLINICAL AND DYNAMIC FEATURES OF SCHIZOPHRENIA COMPLICATED BY NEW DRUGS. Actual Problems of Theoretical and Clinical Medicine. 2020;(3):47-49.
Views:
170
